These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11758081)

  • 1. Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease?
    Ellis PM
    Med J Aust; 2001 Nov; 175(9):492-3. PubMed ID: 11758081
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 3. [AVERT [The Atorvastatin versus Revascularization Treatment]].
    Mokuno H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 5. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the atorvastatin versus revascularization treatment (AVERT) study for the clinician.
    Eisenberg D
    Curr Cardiol Rep; 2000 Sep; 2(5):433-8. PubMed ID: 10980911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Cohen DJ; Carrozza JP; Baim DS
    N Engl J Med; 1999 Dec; 341(24):1853-4; author reply 1854-5. PubMed ID: 10610464
    [No Abstract]   [Full Text] [Related]  

  • 8. Atorvastatin for reduction of myocardial damage during angioplasty trials.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):709-11. PubMed ID: 20815110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atorvastatin in secondary prevention].
    Ongen Z; Yilmaz Y; Karadağ B
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():23-8. PubMed ID: 19404047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin for acute coronary syndromes.
    Wierzbicki AS; Mikhaildis DP; Reynolds TR
    JAMA; 2001 Aug; 286(5):532-3; author reply 533-5. PubMed ID: 11476649
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-lowering therapy in acute coronary syndromes.
    Sacks FM
    JAMA; 2001 Apr; 285(13):1758-60. PubMed ID: 11277832
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of atorvastatin in cholesterol lowering.
    Farmer JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):94-5. PubMed ID: 12573192
    [No Abstract]   [Full Text] [Related]  

  • 15. Profound regression of coronary atherosclerosis with statins.
    Abdallah MH; Karrowni W; Dakik HA
    Can J Cardiol; 2006 Jun; 22(8):709. PubMed ID: 16802002
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
    [No Abstract]   [Full Text] [Related]  

  • 18. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    Malhotra HS; Goa KL
    Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to editor in response to "Prevention of pediatric graft coronary artery disease: atorvastatin", by Chin et al.
    Collins RT; Hanna B; Shaddy RE
    Pediatr Transplant; 2009 Feb; 13(1):141. PubMed ID: 19172670
    [No Abstract]   [Full Text] [Related]  

  • 20. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.